Phase II study of gemcitabine/vinorelbine (GV) as first or second line chemotherapy in patients with metastatic soft tissue sarcoma (STS).

被引:0
|
作者
Morgan, JA [1 ]
George, S [1 ]
Desai, J [1 ]
Amand, MS [1 ]
Horton, D [1 ]
Wilkins, E [1 ]
Manola, J [1 ]
Demetri, GD [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9009
引用
收藏
页码:820S / 820S
页数:1
相关论文
共 50 条
  • [41] Gemcitabine as prolonged infusion and vinorelbine as second-line therapy in metastatic breast cancer: results of a phase-II-study.
    Schmid, P
    Heilmann, V
    Schulz, CO
    Dieing, A
    Lehenhauer-Dehm, S
    Flath, B
    Sezer, O
    Kreienberg, R
    Possinger, K
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S206 - S206
  • [42] A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
    Zachary Veitch
    Alona Zer
    Herbert Loong
    Samer Salah
    Maryam Masood
    Abha Gupta
    Penelope A. Bradbury
    David Hogg
    Andrew Wong
    Rita Kandel
    George S. Charames
    Albiruni R. Abdul Razak
    Scientific Reports, 9
  • [43] First line chemotherapy with ifosfamide (IFO)-doxorubicine (DOX) in unresectable or metastatic soft tissue sarcomas (STS).
    Mañé, JM
    Rubio, I
    Muñoz, A
    Ferreiro, J
    Fernández, R
    Fuente, N
    Abón, G
    Lopez-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 129 - 129
  • [44] A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
    Veitch, Zachary
    Zer, Alona
    Loong, Herbert
    Salah, Samer
    Masood, Maryam
    Gupta, Abha
    Bradbury, Penelope A.
    Hogg, David
    Wong, Andrew
    Kandel, Rita
    Charames, George S.
    Razak, Albiruni R. Abdul
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [45] First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
    Yousaf, Nadia
    Harris, Samuel
    Martin-Liberal, Juan
    Stanway, Susannah
    Linch, Mark
    Ifijen, Maria
    Muderis, Omar Al
    Khabra, Komel
    Fisher, Cyril
    Noujaim, Jonathan
    Judson, Ian
    Benson, Charlotte
    CLINICAL SARCOMA RESEARCH, 2015, 5
  • [46] Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? A single-center phase 2 study
    Rossi, E
    Perrone, F
    Labonia, V
    Landi, G
    Nuzzo, F
    Amabile, G
    Gridelli, C
    Di Maio, M
    D'Aiuto, G
    de Matteis, A
    ONCOLOGY, 2003, 64 (04) : 479 - 480
  • [47] D Outcomes of gemcitabine-docetaxel as second-line chemotherapy in patients of advanced soft tissue sarcoma: A retrospective analysis
    Gupta, K.
    Parthiban, S.
    Kumar, S.
    Srinivas, S.
    Vallathol, D. H.
    Chanana, R.
    Grewal, G. S.
    Rathnasamy, N.
    Goel, A.
    Bajpai, J.
    ANNALS OF ONCOLOGY, 2018, 29 : 128 - 128
  • [48] Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy
    Ray-Coquard, I.
    Rizzo, E.
    Blay, J. Y.
    Casali, P.
    Judson, I.
    Hansen, A. Krarup
    Lindner, L. H.
    dei Tos, A. P.
    Gelderblom, H.
    Marreaud, S.
    Litiere, S.
    Rutkowski, P.
    Hohenberger, P.
    Gronchi, A.
    van der Graaf, W. T.
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 95 - 101
  • [49] Vinorelbine and infusional 5-fluorouracil as first line chemotherapy in elderly patients with metastatic breast cancer: a phase II study.
    Rozzi, A
    Salerno, M
    Ciorra, AA
    Traficante, D
    Magnolfi, E
    De Pettis, L
    Gemma, D
    Marchei, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S91 - S91
  • [50] First-Line Therapy for Metastatic Soft Tissue Sarcoma
    Meyer, Megan
    Seetharam, Mahesh
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (01)